Literature DB >> 28132981

Difference of Tissue Characteristics Between Early and Late Restenosis After Second-Generation Drug-Eluting Stents Implantation - An Optical Coherence Tomography Study.

Hiroyuki Jinnouchi1, Shoichi Kuramitsu, Tomohiro Shinozaki, Yusuke Tomoi, Takashi Hiromasa, Yohei Kobayashi, Takenori Domei, Yoshimitsu Soga, Makoto Hyodo, Shinichi Shirai, Kenji Ando.   

Abstract

BACKGROUND: The mechanism and time course of in-stent restenosis (ISR) after implantation of second-generation DES have not yet been fully elucidated. We sought to evaluate the differences in tissue characteristics between the different phases of ISR after second-generation DES implantation using optical coherence tomography (OCT).Methods and 
Results: From June 2010 to December 2015, 324 consecutive patients with 337 ISR lesions underwent OCT. Of these, we analyzed 53 lesions in 53 patients who had their first ISR after second-generation DES implantation and underwent OCT before any procedures. According to the timing of ISR, the patients were divided into the early group (within 1 year: E-ISR, n=30) and late group (beyond 1 year: L-ISR, n=23). Quantitative parameters and qualitative characteristics of the neointima were evaluated. In the minimum lumen area site analysis, the E-ISR group had more frequently homogeneous intima than the L-ISR group (26.7% vs. 4.4%, P=0.02). The frequencies of neointima with lipid-laden, thin-cap fibroatheroma, neovascularization and macrophage infiltration were significantly higher in the L-ISR group than in the E-ISR group (30.0% vs. 69.6%, P<0.01; 0.0% vs. 26.1%, p <0.01; 6.7% vs. 26.1%, P=0.049; 3.3% vs. 26.1%, P=0.01, respectively).
CONCLUSIONS: Neointimal tissue characteristics differed between E-ISR and L-ISR after second-generation DES implantation. E-ISR was mainly caused by neointimal hyperplasia, whereas neoatherosclerosis was the main mechanism of L-ISR.

Entities:  

Mesh:

Year:  2017        PMID: 28132981     DOI: 10.1253/circj.CJ-16-1069

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  14 in total

1.  Comparison of in-stent neoatherosclerosis and tissue characteristics between early and late in-stent restenosis in second-generation drug-eluting stents: an optical coherence tomography study.

Authors:  Mahmoud Sabbah; Kazushige Kadota; Azza El-Eraky; Hanan M Kamal; Ahmed-Tageldien Abdellah; Ahmed El Hawary
Journal:  Int J Cardiovasc Imaging       Date:  2017-04-25       Impact factor: 2.357

2.  In-stent restenosis assessed with frequency domain optical coherence tomography shows smooth coronary arterial healing process in second-generation drug-eluting stents.

Authors:  Takashi Kajiya; Hiroshi Yamaguchi; Junichiro Takaoka; Kengo Fukunaga; Ryoichi Arima; Akihiro Miyamura; Toshiko Ninomiya; Nobuhiko Atsuchi; Yoshihiko Atsuchi; Mitsuyasu Terashima; Hideaki Kaneda; Mitsuru Ohishi
Journal:  Singapore Med J       Date:  2018-04-10       Impact factor: 1.858

3.  Reduced histologic neo in-stent restenosis after use of a paclitaxel-coated cutting balloon in porcine coronary arteries.

Authors:  Denise Traxler; Rayyan Hemetsberger; Andreas Spannbauer; Katrin Zlabinger; Alfred Gugerell; Dominika Lukovic; Ljubica Mandic; Noemi Pavo; Johannes Winkler; Mariann Gyöngyösi
Journal:  Histol Histopathol       Date:  2019-10-24       Impact factor: 2.303

Review 4.  Drug-eluting coronary stents: insights from preclinical and pathology studies.

Authors:  Sho Torii; Hiroyuki Jinnouchi; Atsushi Sakamoto; Matthew Kutyna; Anne Cornelissen; Salome Kuntz; Liang Guo; Hiroyoshi Mori; Emanuel Harari; Ka Hyun Paek; Raquel Fernandez; Diljon Chahal; Maria E Romero; Frank D Kolodgie; Anuj Gupta; Renu Virmani; Aloke V Finn
Journal:  Nat Rev Cardiol       Date:  2019-07-25       Impact factor: 32.419

5.  [Carotid intraplaque neovascularization is correlated with the risk of revascularization following percutaneous coronary intervention].

Authors:  Y Han; X Fei; L Ren; J Wang; T Chen; J Guo; Q Wang
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-06-20

6.  The Predictive Value of the Perivascular Adipose Tissue CT Fat Attenuation Index for Coronary In-stent Restenosis.

Authors:  Bin Qin; Zhengjun Li; Hao Zhou; Yongkang Liu; Huiming Wu; Zhongqiu Wang
Journal:  Front Cardiovasc Med       Date:  2022-04-26

7.  Berberine alleviates oxidized low-density lipoprotein-induced macrophage activation by downregulating galectin-3 via the NF-κB and AMPK signaling pathways.

Authors:  ChongZhe Pei; Yi Zhang; Ping Wang; BeiJian Zhang; Lu Fang; Bo Liu; Shu Meng
Journal:  Phytother Res       Date:  2018-11-06       Impact factor: 5.878

Review 8.  Vascular Wall Reactions to Coronary Stents-Clinical Implications for Stent Failure.

Authors:  Tommaso Gori
Journal:  Life (Basel)       Date:  2021-01-17

9.  Durable endothelium-mimicking coating for surface bioengineering cardiovascular stents.

Authors:  Qing Ma; Xiuying Shi; Xing Tan; Rui Wang; Kaiqin Xiong; Manfred F Maitz; Yuanyuan Cui; Zhangmei Hu; Qiufen Tu; Nan Huang; Li Shen; Zhilu Yang
Journal:  Bioact Mater       Date:  2021-05-24

10.  Impact of hyperuricemia on clinical outcomes after percutaneous coronary intervention for in-stent restenosis.

Authors:  Hyung Joon Joo; Han Saem Jeong; Hyungdon Kook; Seung Hun Lee; Jae Hyoung Park; Soon Jun Hong; Cheol Woong Yu; Do-Sum Lim
Journal:  BMC Cardiovasc Disord       Date:  2018-06-11       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.